1958
DOI: 10.1111/j.1749-6632.1958.tb42682.x
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Trials of Nonane in Malignant Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1959
1959
1969
1969

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 9 publications
0
1
0
Order By: Relevance
“…1) is the first member of a homologous series of which Busulphan (Fig. 1, n-4) (Haddow and Timmis, 1953) and Nonane (n-9) (Miller, 1961) are wellknown anti-tumour alkane sulphonates employed clinically. The series from n =2 to n = 18 has been investigated in some detail (Carlson and Morgan, 1954;Ross, 1962) and some of the chemical (Emmons and Ferris, 1953) and biological (Fox and Jackson, 1965;James, 1966;Crystal, 1968) properties of the methylene derivative (n= 1) have also been reported.…”
mentioning
confidence: 99%
“…1) is the first member of a homologous series of which Busulphan (Fig. 1, n-4) (Haddow and Timmis, 1953) and Nonane (n-9) (Miller, 1961) are wellknown anti-tumour alkane sulphonates employed clinically. The series from n =2 to n = 18 has been investigated in some detail (Carlson and Morgan, 1954;Ross, 1962) and some of the chemical (Emmons and Ferris, 1953) and biological (Fox and Jackson, 1965;James, 1966;Crystal, 1968) properties of the methylene derivative (n= 1) have also been reported.…”
mentioning
confidence: 99%